Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Animal Genetics Certified to Offer Illumina Bovine BeadChip to Beef Industry


By Justin Petrone

Pfizer Animal Genetics's lab in Kalamazoo, Mich., was recently certified to offer cattle testing services on the Illumina Bovine SNP50 BeadChip platform, Pfizer said this week. Pfizer Animal Genetics is a business unit of Pfizer Animal Health.

Pfizer said the certification "reaffirms" its "commitment and investment in cutting-edge genomic technology to support livestock producers."

The Bovine SNP50 was developed by Illumina in collaboration with the US Department of Agriculture's Agricultural Research Service, the University of Missouri, and the University of Alberta. The BeadChip contains 54,609 SNPs distributed across the genomes of major cattle breed types. Illumina markets the chip for use in genome-wide enabled selection, identification of quantitative trait loci, evaluation of genetic merit of individuals, and comparative genetic studies, according to its website.

According to Pfizer, the recent certification is "especially important," as it allows the Michigan lab to offer the "beef industry’s first and only high-density DNA panel to identify more than 50,000 DNA markers for each tested animal."

The Illumina certified service provider, or CSPro, program is a partnership dedicated to ensuring the "delivery of the highest-quality data available for genetic analysis applications," Pfizer said. CSPro participants undergo a "rigorous" two-phase certification process that includes minimum data generation, data certification, and an on-site audit of the facility and processes, the pharmaceutical company added.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.